California Public Employees Retirement System Akebia Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.83 - $4.2 $824,379 - $1.22 Million	-291,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$2.92 - $5.06 $83,237 - $144,240	-28,506 Reduced 8.91%	291,300 $986,000
Q4 2020 Feb 02, 2021	SELL	$2.22 - $3.78 $13,542 - $23,058	-6,100 Reduced 1.87%	319,806 $895,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $13.08 $85,698 - $469,009	35,857 Added 12.36%	325,906 $818,000
Q2 2020 Aug 12, 2020	BUY	$6.67 - $13.58 $177,215 - $360,807	26,569 Added 10.08%	290,049 $3.94 Million
Q1 2020 May 12, 2020	BUY	$4.1 - $10.24 $124,967 - $312,115	30,480 Added 13.08%	263,480 $2 Million
Q4 2019 Jan 27, 2020	BUY	$3.16 - $6.73 $264,450 - $563,213	83,687 Added 56.05%	233,000 $1.47 Million
Q3 2019 Oct 31, 2019	BUY	$3.55 - $5.4 $102,240 - $155,520	28,800 Added 23.9%	149,313 $585,000
Q2 2019 Aug 15, 2019	BUY	$4.1 - $8.05 $25,419 - $49,910	6,200 Added 5.42%	120,513 $583,000
Q4 2018 Feb 08, 2019	BUY	$5.39 - $9.15 $276,436 - $469,276	51,287 Added 81.37%	114,313 $632,000
Q3 2018 Nov 13, 2018	SELL	$7.44 - $10.65 $34,224 - $48,990	-4,600 Reduced 6.8%	63,026 $557,000
Q2 2018 Aug 15, 2018	BUY	$9.15 - $11.34 $60,627 - $75,138	6,626 Added 10.86%	67,626 $675,000
Q4 2017 Feb 06, 2018	BUY	$14.24 - $19.59 $28,480 - $39,180	2,000 Added 3.39%	61,000 $907,000
Q3 2017 Nov 15, 2017	BUY	$13.06 - $19.67 $770,540 - $1.16 Million	59,000	59,000 $1.16 Million

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$20.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$17.7 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.1 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$8.37 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$6.54 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account